Cargando…
Remittance of primary cutaneous CD30(+) lymphoproliferative disorder in a patient on adalimumab
Autores principales: | Ottevanger, Rosanne, Melchers, Rutger C., Quint, Koen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904182/ https://www.ncbi.nlm.nih.gov/pubmed/35274033 http://dx.doi.org/10.1016/j.jdcr.2022.02.003 |
Ejemplares similares
-
CD30+ Primary Cutaneous Post-transplant Lymphoproliferative Disorder with Signet-ring Cell Features
por: Malviya, Neeta, et al.
Publicado: (2016) -
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
por: Abdulla, Farah R., et al.
Publicado: (2021) -
CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
por: Prieto-Torres, Lucia, et al.
Publicado: (2019) -
Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity
por: Saleh, Jamal Z., et al.
Publicado: (2016) -
Primary cutaneous CD4+ small‐/medium‐sized T‐cell lymphoproliferative disorder: A case report
por: Koper, Monika, et al.
Publicado: (2019)